Vision

First Swiss Liquid Biopsy Multi-Cancer Assay.

Today, diagnostics for the most prominent cancer types are not qualified enough. Time and money consuming cascades of several diagnostic methods have to be applied. Therefore, 4D Lifetec invested in the development of an innovative cost-efficient and easy to apply 4D Lifetest™ Liquid Biopsy to detect various types of cancer.

 

With a few drops of patient’s blood, 4D Lifetest™ eradicates unclear or false positive results deriving from existing diagnostic methods within shortest time. Thus, 4D Lifetest™ will contribute efficiently to the verification of primary diagnostic of various types of cancer and in addition opens the door for an effective, early stage cancer screening.

The propietary and fully patented 4D Lifetest™ is just before approval for the CE market, which is expected for the first application by the end of 2020. Our clinical data show that 4D Lifetest™ detects lung, breast, colon, and prostate cancer with outstanding sensitivity and selectivity within a few drops of blood. In addition our assay has proven to detect cancer in all stages with the same high sensitivity. Therefore our non-genomic 4D Lifetest™ has the unique potential to fulfill one of the central promises of liquid biopsy and detect cancer realy in an early stage. 

 

Our current investment thesis can be summarized as follows:

 

  • Proprietary, fully IP protected liquid biopsy technology platform for the early detection of multiple types of cancer
  • Robust, easy-to-handle non-genomic assay with high throughput design (max. 10’000 samples per instrument per day) allowing full economy of scales
  • Highly competitive clinical results based on sensitivity and specificity compared to other leading biomarkers with a fraction of funds invested so far
  • Various contracts with leading Diagnostics Companies as strategic partners under negotiation
  • IVD certification for 4D Lifetest™ LC (Lung Cancer) expected by the end of 2020 for the use in personalized diagnostics
  • Looking for funding to start commercialization in the US with first revenues planned for 2021 and break even in 2022 for the first two applications (lung and prostate)

 

 

A dedicated Management Team supported by Key Experts

4D Lifetec AG is a highly innovative Swiss start up founded 2014 by Dr. Arne Faisst and Nick Mijnssen. We have set up an experienced motivated team of experts to create a footprint in the world of cancer diagnostics. Reaching today’s status, 4D Lifetec AG needs more hands to maintain dynamics and consolidate processes and services with our partners, suppliers and customers. A scientific board is currently institutionalized and expanded.

Team

  • Exec. MBA at State University at Albany, New York
  • PhD in Virology at University of Göttingen
  • MSc in Biochemistry at University of Göttingen
  • Active in the Medtech Industry since 1989 (Fresenius, Synthes, Mathys, Cendres+Métaux) in various national and international positions in Germany, France, US, Netherlands and Switzerland
  • Long term experience in the field of Life Science (Biochemistry, Molecular Cell Biology and Virology)
  • 8 years CEO and Member of Board of Directors of the Mathys Group.
  • Since 2013 owner and CEO of anfass Life Technologies AG, family office and service provider for Active Trust Management
  • Experienced manager with deep understanding of healthcare markets in Europe, Asia and the US

 

  • Exec. MBA at Lorange Institute of Business, Zurich and University of Wales, Cardiff
  • PhD in Technical Mineralogy at University of Berne
  • MSc in Mineralogy at University of Berne
  • Active in the Medtech Industry (Synthes, Mathys, Heraeus) since 2001 in various national and international positions

  • Experienced global executive with broad and deep understanding of healthcare markets and working experience from Science to Sales

  • Since 2014 engaged in active trust management at anfass Life Technologies AG

  • Since 2006 Member of Executive Committee and Treasurer of Swiss Society for Biomaterials and Regenerative Medicine

 

  • Exec. MBA at China Europe International Business School
  • MBA at Lorange Institute of Business, Zurich
  • PhD in Biochemistry at University of Zurich
  • Dipl. Ing. in Chemistry at TU Darmstadt
  • Active in Life science and Laboratory automation since 2007 in various positions
  • Extensive international project management experiences in laboratory automation and life science
  • PhD in Natural Sciences at University of Zurich
  • Master in Molecular and Cellular Biology
  • Deep experience in molecular cancer research
  • PhD in Molecular Biology
  • Editor
  • Experienced pharma R&D professional and biomarker scientist
  • Deep expertise in diagnostically, pre-clinically and clinically applied nucleic acid analytical technologies
  • CAS in Digital Transformation and Marketing 
  • Marketing Manager with Swiss Federal Certificate and several years of experience in marketing management
  • Specific focus on digital marketing projects and programs from her time working for a interactive marketing agency
  • Experienced in the field of insurance companies and in the sector of Life Science
  • Long time experience in organisation and administration of back office solutions at different levels and industries

Board Member

  • Exec. MBA at State University at Albany, New York
  • PhD in Virology at University of Göttingen
  • MSc in Biochemistry at University of Göttingen
  • Active in the Medtech Industry since 1989 (Fresenius, Synthes, Mathys, Cendres+Métaux) in various national and international positions in Germany, France, US, Netherlands and Switzerland
  • Long term experience in the field of Life Science (Biochemistry, Molecular Cell Biology and Virology)
  • 8 years CEO and Member of Board of Directors of the Mathys Group.
  • Since 2013 owner and CEO of anfass Life Technologies AG, family office and service provider for Active Trust Management
  • Experienced manager with deep understanding of healthcare markets in Europe, Asia and the US

Scientific Advisors

  • Senior Physician & Oncologist
  • Department of Radiation Oncology
  • Universitätsklinikum Freiburg i.B.

Contact

4D Lifetec AG
Gewerbestrasse 8
6330 Cham
Switzerland


info@4dlifetec.com
Phone +41 41 747 25 52

 

Xing

LinkedIn

Partners

empa logo 300pxCentre de Recherches en Canérologie ToulouseUniversité Toulouse

Inserm Science Health

 

 

 

 

 

 

University of Leicester